Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
startups
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
avrobio
biology
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brexanolone
camp4 therapeutics
cancer
cancer immunotherapy
clinical trials
crispr therapeutics
crispr-cas9
deals
denali therapeutics
detroit blog main
detroit top stories
eidos therapeutics
endeavor
estradiol
f-star gamma
fda
food and drug administration
fundings & exits
gene editing
genmab
health
ido inhibitors
incyte
indiana blog main
indiana top stories
investing
johnson & johnson
joseph payne
larotrectinib
What
focus
2
×
key
2
×
ahead
ambien
american
annual
asco
attendees
attention
biopharmaceutical
biotech
called
camp’s
cancer
cash
celgene
cells
celularity
chicago
city
clinical
combinations
community’s
company
creating
days
derived
diamandis
drug
endeavor
expanding
founder
gene
global
hold
home
human
kicks
medicine
meeting
Language
Current search:
key
×
biotech
×
focus
×
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@techcrunch.com
6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas